GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary…
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting 2025
Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in…
Cellectis to Report Third Quarter Financial Results on November 7, 2025
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety…
Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 3, 2025,…
ASM hosts Investor Day, provides new 2030 targets, revises H2 2025 outlook
Almere, The Netherlands September 23, 2025, 7:45 a.m. CET ASM International N.V.…
Eutelsat and Multimedios Televisin Consolidate Longstanding Satellite Partnership in Mexico
Multimedios Televisión renews capacity on EUTELSAT 117 West A satellite for media…
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program…
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”)…
Ipsen – July 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…